Elanco names Lawrence Kurzius next Chairman; proposes board declassification and majority voting

Elanco Animal Health Inc

Lawrence Kurzius to become Chairman after 2024 annual meeting; R. David Hoover remains on board.
Board to declassify, grant shareholders rights to amend bylaws and call special meetings.
Company to seek approval to change director elections from plurality to majority of votes cast.
Post-meeting: Michael Harrington to chair Corporate Governance, Kirk McDonald to chair Compensation Committee.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.